Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biomarkers, Pharmacological”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Early research (Phase 1)WithdrawnNCT01491139
What this trial is testing

Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
University College, London
Not applicableLooking for participantsNCT07324330
What this trial is testing

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+7 more
University Hospital, Bonn 130
Post-approval studies (Phase 4)Study completedNCT01743560
What this trial is testing

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

Who this might be right for
Oestrogen Receptor Positive Advanced Breast Cancer
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT02325414
What this trial is testing

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

Who this might be right for
Spinal Cord InjuryAcute Spinal Cord InjuryBone Loss+1 more
Northwestern University 60
Large-scale testing (Phase 3)Ended earlyNCT02505087
What this trial is testing

Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)

Who this might be right for
Selenoprotein N-related Myopathy
Assistance Publique - Hôpitaux de Paris 7
Not applicableLooking for participantsNCT07251296
What this trial is testing

Impact of Funcional Exercise and Supplementation in Perimenopausal Women's Health

Who this might be right for
PerimenopauseAging
University of Valencia 90
Testing effectiveness (Phase 2)Study completedNCT00278083
What this trial is testing

TNF-alpha Directed Therapy in Asthma

Who this might be right for
Asthma
Imperial College London 40
Not applicableStudy completedNCT06699238
What this trial is testing

Effect of Aerobic Exercises on Axial Spondyloarthropathy

Who this might be right for
Axial Spondyloarthritis (AxSpA)Aerobic ExerciseDisease Activity
Yeşim Ozge Gunduz Gul 54
Early research (Phase 1)Study completedNCT02419560
What this trial is testing

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

Who this might be right for
Lymphoma, Mantle-CellRecurrent Lymphoma, Mantle-Cell
Craig Portell, MD 37
Early research (Phase 1)Looking for participantsNCT07084129
What this trial is testing

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

Who this might be right for
Sepsis
Children's Hospital of Philadelphia 20
Not applicableStudy completedNCT01039480
What this trial is testing

Aspirin and Clopidogrel Resistance Study

Who this might be right for
Drug Resistance
University Hospital, Basel, Switzerland 82
Not applicableStudy completedNCT03541395
What this trial is testing

Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males

Who this might be right for
Hypogonadism, Male
Lund University 30
Not applicableStudy completedNCT07470554
What this trial is testing

BIOmarker Based Diagnostic TOOLkit to Personalize Pharmacological Approaches in Congestive Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Congestive Heart Failure(CHF)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 4,254
Not applicableNot Yet RecruitingNCT06933134
What this trial is testing

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
University Hospital, Tours 30
Not applicableNot Yet RecruitingNCT07441915
What this trial is testing

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

Who this might be right for
Parkinson's DiseaseMild Cognitive Impairment
University of Zurich 50
Not applicableNot Yet RecruitingNCT07097103
What this trial is testing

Parkinson's Research In Metagenomic Early Stage Biomarkers

Who this might be right for
Parkinson's Disease (PD)
IRCCS San Raffaele Roma 80
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Not applicableStudy completedNCT04279418
What this trial is testing

Non-pharmacological Intervention for Preclinical Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseFunctional FoodSubjective Cognitive Decline+2 more
XuanwuH 2 60
Not applicableLooking for participantsNCT04067674
What this trial is testing

Septic Shock-induced Immunosuppression

Who this might be right for
Septic Shock
Hospices Civils de Lyon 305
Not applicableUnknownNCT01746823
What this trial is testing

Identification and Validation of Functional Biomarkers for Keratoconus

Who this might be right for
Keratoconus
Narayana Nethralaya 200
Load More Results